Total revenues for Q2 2026 reached $68.7 million, up from $65.9 million in Q2 2025. Net loss attributable to common stockholders was $0.3 million, or $(0.04) per share, impacted by $7.6 million in net impairment and other charges. Non-GAAP EPS increased to $0.78 from $0.65 in the year-ago period. Adjusted EBITDA rose to $15.6 million compared to $14.2 million in Q2 2025. Free cash flow improved to $8.4 million from $6.9 million in the prior year. Weighted average shares outstanding decreased by 12.6% to 7.74 million due to ongoing share buybacks.